In patients with type 2 diabetes mellitus (T2DM), the secretion of glucagon is increased in both the fasting and postprandial states and contributes to pathogenesis of diabetic hyperglycemia through excessive hepatic glucose production and output5, 6. This evidence concerns the gene GCG and type 2 diabetes mellitus.